Sanofi to invest in mRNA vaccines development | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
May 29, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, MAY 29, 2025
Sanofi to invest in mRNA vaccines development

Coronavirus chronicle

Reuters
29 June, 2021, 08:45 pm
Last modified: 29 June, 2021, 08:47 pm

Related News

  • How Renata's Tk1,000cr investment plan became a Tk1,400cr problem
  • Health workers, employed during pandemic, call for job security after four years of service
  • Covid-19 disrupted progress on Measles, Rubella elimination: WHO
  • World better positioned against mpox than for Covid: Vaccine alliance
  • US FDA approves updated Covid shots ahead of fall and winter

Sanofi to invest in mRNA vaccines development

Sanofi added on Tuesday that its "mRNA Center of Excellence" will bring together around 400 employees based at existing sites close to Lyon in southern France and in Cambridge, Massachusetts

Reuters
29 June, 2021, 08:45 pm
Last modified: 29 June, 2021, 08:47 pm
Sanofi to invest in mRNA vaccines development

Sanofi will invest about 400 million euros ($476 million) annually in research and development of next-generation vaccines using mRNA technologies, which proved their efficiency in the Pfizer and Moderna Covid-19 jabs.

Sanofi added on Tuesday that its "mRNA Center of Excellence" will bring together around 400 employees based at existing sites close to Lyon in southern France and in Cambridge, Massachusetts. It is expected to produce a minimum of six clinical candidates by 2025.

"During the Covid-19 pandemic, mRNA technologies demonstrated potential to deliver new vaccines faster than ever before", said Jean-Francois Toussaint, global head of R&D at Sanofi Pasteur, the company's vaccines division.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

"However, key areas of innovation such as thermostability and tolerability improvements will be critical to unlock the applications of mRNA in routine vaccination against a broader set of infectious diseases and across all ages," he added.

The French drug company and its British counterpart GlaxoSmithKline disappointed investors and customers late last year when they announced a one-year delay to the launch of their joint Covid vaccine, based on a more conventional technology.

Sanofi has since pledged to help Pfizer and Moderna manufacture Covid-19 shots in an effort to help meet the huge demand for the U.S. drugmaker's doses.

The mRNA technology has proven both effective and safe so far in the vaccine response to Covid-19, including in response to the virus' variants.

The latest one, the Delta variant first found in India, is spreading at a fast rate around the world, prompting governments to accelerate their vaccinations programs.

French Health Minister Oliver Veran said on Tuesday that the Delta variant represented some 20 percent of Covid cases in France.

Sanofi is also working on a mRNA Covid-19 vaccine candidate with U.S. company Translate Bio, for which it has started clinical trials.

The two groups, which have been collaborating since 2018, have also started a Phase I clinical trial earlier this year evaluating an mRNA-based investigational vaccine against seasonal influenza.

Last month, Sanofi and GlaxoSmithKline launched a late-stage human trial for their Covid-19 vaccine candidate, which they hope to get approved by the end of 2021.

($1 = 0.8397 euros)

Sanofi / COVID-19 / mRNA vaccines

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Illustration: Duniya Jahan/TBS
    Tax gap between listed and non-listed firms may widen to 7.5% 
  • Incessant raining since this morning (29 May) caused intense traffic congestion on almost all the streets in the capital. The photo was taken from Tejgaon Industrial Area. Photo: Syed Zakir Hossain/TBS
    Commuters suffer as rain causes intense traffic congestion on city roads
  • Photo: Courtesy
    New notes featuring historic, archaeological structures of Bangladesh to be circulated from 1 June

MOST VIEWED

  • Google Pay. Photo: Collected
    Google Pay likely coming to Bangladesh soon
  • IFIC Bank receives Tk6,000 cr in new deposits in six months
    IFIC Bank receives Tk6,000 cr in new deposits in six months
  • Dhaka areas at a gridlock on Wednesday, 28 May 2025. Photo: Syed Zakir Hossain/TBS
    BNP, Jamaat rallies: Traffic clogs Dhaka roads, including Motijheel, Paltan, Dainik Bangla intersection
  • Abdul Awal Mintoo, chairman of National Bank Limited. Sketch: TBS
    'Regulatory support must for National Bank to restore depositors' confidence'
  • Mohammad Abdul Mannan, chairman FSIB Ltd. Sketch: TBS
    FSIB to bounce back soon
  • Mohammad Mamdudur Rashid, managing director and CEO, UCB. Sketch: TBS
    Customers’ trust and confidence fueling deposit growth at UCB

Related News

  • How Renata's Tk1,000cr investment plan became a Tk1,400cr problem
  • Health workers, employed during pandemic, call for job security after four years of service
  • Covid-19 disrupted progress on Measles, Rubella elimination: WHO
  • World better positioned against mpox than for Covid: Vaccine alliance
  • US FDA approves updated Covid shots ahead of fall and winter

Features

In recent years, the Gor-e-Shaheed Eidgah has emerged as a strong contender for the crown of the biggest Eid congregation in the country, having hosted 600,000 worshippers in 2017. Photo: TBS

Gor-e-Shaheed Boro Maath: The heart of Dinajpur

2d | Panorama
The Hili Land Port, officially opened in 1997 but with trade roots stretching back to before Partition, has grown into a cornerstone of bilateral commerce.

Dhaka-Delhi tensions ripple across Hili’s markets and livelihoods

3d | Panorama
Photo: Collected

Desk goals: Affordable ways to elevate your study setup

3d | Brands
Built on a diamond-type frame, the Hornet 2.0 is agile but grounded. PHOTO: Asif Chowdhury

Honda Hornet 2.0: Same spirit, upgraded sting

3d | Wheels

More Videos from TBS

Trump's tariffs on various countries are illegal: US court

Trump's tariffs on various countries are illegal: US court

21m | TBS World
Politics should be done openly, not secretly, in every educational institution

Politics should be done openly, not secretly, in every educational institution

51m | TBS Today
Elon Musk steps down as head of DOGE under Trump administration

Elon Musk steps down as head of DOGE under Trump administration

2h | TBS World
Low Pressure over the Bay of Bengal, Signal No. 3 Issued for Sea Ports

Low Pressure over the Bay of Bengal, Signal No. 3 Issued for Sea Ports

3h | TBS Today
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net